If you’re new to weight loss treatments and want to learn more about them, we’re here to help.
Tablets like (the brand name for Orlistat) work by reducing the amount of fat your body absorbs. Ordinarily, fats are broken down during the digestion process by enzymes called lipases. Xenical prevents these enzymes from working effectively, limiting how much fat your body is able to absorb. The remaining, undigested fat is then excreted.
In contrast to Xenical, weight loss injections (or pens) work by suppressing your appetite - particularly your appetite for fatty foods. Some weight loss injections also slow the digestion process down, making you feel fuller for longer. They’re simple to use - check out our for more information.
Clinical trials have repeatedly demonstrated the effectiveness of both weight loss tablets and injections, particularly in combination with a healthy diet and lifestyle., participants using lost almost 15% of their body weight over a 15-month period.
Starting your weight loss journey is simple with IQ Doctor. To begin, click on a product and then hit the 'Start Consultation' button. The online consultation process is quick, simple and free; just complete the form and we’ll verify whether the medication is suitable for you or not. If it is, you can then place your order and receive it the very next day.
Send messageTake the online consultation to the visit page and answer a few questions about your medical history and treatment plan.
Take the medication as you would anyICAL - the same acting as an implant or weight loss injection. The solution is then stored at a controlled room temperature - no continued exposure to heat or moisture is allowed.
Alli is supplied by appropriate pharmacies and is kept on a shelf at a controlled room temperature with no direct sunlight. Alli Care ensures that your medication is suitable for your personal use, but in most cases it may not be for your other treatments.
In the current scenario, you can expect to receive your list of treatments within 2 weeks of being submitted. When placed, your treatments will begin to lose almost 15% of your body weight over 15 months - potentially leading to you feeling a little fuller.
ConsultationAlli has been reported to cause some side effects. Some of the most common are:
If you experience any of these symptoms while using your treatments, it’s important to discuss them with your doctor. If you experience a pregnancy related side effect or breastfeeding related symptoms, seek medical advice before using any hormonal solution.
Alli is supplied by controlled room temperature with no direct sunlight. Your medication is then stored at a controlled room temperature with no direct sunlight.
TakeawayIf you’re planning to take steps to avoid pregnancy, it is recommended that you consult with your healthcare provider. This will ensure that your medication is suitable for your treatment and minimize the risk of unwanted side effects. If you’re pregnant, or breastfeeding, seek medical advice before using any hormonal solution.
Yes. Consulting with a healthcare provider is important for optimal effectiveness and safety. You should not operate a motor vehicle without consulting with your healthcare provider. Your medical history should also be complete to ensure the appropriate dosage and usage of your treatment will be safe and appropriate for you.
In recent years, the efficacy of a class of pharmacologic agents (e.g., non-selective) has been explored in a number of clinical contexts, including the use of the lipase inhibitor, orlistat, in the treatment of obesity. Although the therapeutic use of lipase inhibitors for obesity is limited, there is compelling evidence from animal and human models that they are effective, with a high efficacy rate. We have recently reported that orlistat reduces body weight in obese subjects and that this reduction is associated with a reduction in weight regain and maintenance of weight-related health-related quality of life (see the reviews “” and “” in this issue). We previously reported that orlistat decreases body weight in subjects with pre-diabetes, and we showed that this effect was independent of glucose and insulin sensitivity. In the present study we evaluated whether orlistat is associated with weight loss in overweight and obese subjects. We hypothesized that orlistat would lead to an increase in body weight. In the present study we have shown that orlistat reduces body weight in subjects with pre-diabetes, and that this effect is independent of glucose and insulin sensitivity.
In a study of obese subjects, we assessed the effects of orlistat on body weight and the risk of chronic weight regain (CHR). Body weight and waist circumference were measured in the first 6 months of treatment with orlistat in 120 overweight and obese subjects.
Methods
Subjects were healthy 18–59 years old, with a body mass index (BMI) of 30 kg/m2 or less, who were taking a semaglutide medication (Orlistat, GlaxoSmithKline, Inc.) for the treatment of obesity and were clinically stable on an oral glucose tolerance test (1–4 hr after the dose). The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Peking University Medical Center (approval number: IRB No. 2022-06-05). Subjects were excluded from the study if they were: (1) patients with type 2 diabetes mellitus, (2) patients on an insulin therapy, (3) subjects with significant insulin resistance (fasting blood glucose greater than 2 mmol/L, or higher than 3 mmol/L, or fasting insulin greater than 5.0 mmol/L, or higher than 6.0 mmol/L, or fasting serum insulin greater than 0.9 mmol/L); (4) patients who were obese or had been clinically stable on insulin or were taking an oral diabetes medication (orlistat). Exclusion criteria were as follows: (1) history of ketoacidosis (e.g., a ketoacidosis or hypothermia), (2) severe renal impairment (e.g., renal failure requiring dialysis, severe hepatic or hepatic encephalopathy, severe heart failure, or acute congestive heart failure); (3) uncontrolled diabetes mellitus, (4) patients with a BMI greater than 30 kg/m2 or other risk factors (e.g., diabetes mellitus, uncontrolled hypertension, or other metabolic disease); (5) subjects who were taking any of the following drugs (including non-selective anti-obesity medications such as orlistat, phentermine, or theophylline); (6) subjects who had previously undergone a randomised controlled trial; (7) subjects who had a previous history of pancreatitis; (8) subjects who were taking an oral diabetes medication (e.g., glyburide or pioglitazone, orlistat) or had been taking an oral insulin medication (e.g., insulin with a high oral insulin dose, orlistat with a high oral insulin dose); (9) subjects who had ever undergone a randomised controlled trial (e.g., a randomised trial of an oral insulin or a glucagon-like peptide-1 receptor agonist); (10) subjects who had a history of cardiovascular events (e.g., myocardial infarction, strokes, or ventricular arrhythmia); (11) subjects who were on any of the following medications (e.g., atorvastatin, orlistat); (12) subjects who had an active peptic ulcer disease, (13) subjects who had a history of gastric or duodenal ulcer or perforation or bleeding, (14) subjects who were using any of the following other medications (e.g.
Orlistat has been shown to cause mild side effects in some individuals. Talk to your health care provider if these do not go away within a few days. If you begin to experience more serious effects, seek medical attention immediately.
Common side effects of orlistat use include:
More serious side effects include:
If you experience any of these side effects, seek medical attention immediately. These are symptoms of a serious adverse reaction–or allergic reaction–to this medication and require treatment right away.
Orlistat has been shown to affect the absorption of fat-soluble vitamins (vitamin A, D, E and K). This can prevent individuals taking this medication from receiving valuable nutrients from their food. Your doctor may recommend that you take a multivitamin and beta-carotene supplement along with this medication to ensure that you are receiving adequate nutrition from the food you eat.
As with all medication, inform your health care provider of any medical conditions you are currently managing. Let them know if you have or ever had kidney stones, diabetes, liver disease, gallbladder disease, thyroid disease, or an eating disorder (anorexia or bulimia). In addition, you should tell them if you have ever had an organ transplant, cholestasis (reduced or stopped bile flow), or malabsorption syndrome.
Tell your provider about any and all medication, prescription drugs, and supplements you are taking before starting treatment with orlistat. Orlistat can interact with substances in the body, causing potentially serious adverse reactions. Specifically, you should inform them of any immunosuppressant medication you are currently taking, such as cyclosporine. You should also let your provider know if you are currently taking blood thinners–like warfarin–or diabetes medication–like metformin.
In addition, let your doctor know if you are planning to become pregnant, are pregnant, or are currently breastfeeding before starting treatment with this medication.
Let your doctor know if you are:You should use only type 2–mouth barrier–capsule or oral suspension– to treat infections, autoimmune infections, or other uses for at least 6 hours. Oral contraceptives should never be used post–exposure. If you are currently taking any————icompetent treatment,asionally, you should let your provider know,asionally diarrhea or constipation.
Orlistat is used to treat obesity and help in weight loss. Orlistat is to be used along with a low-calorie diet and regular physical exercise. Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers, and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity.
Orlistat contains Orlistat, which works in the small intestine and stomach and prevents the action of enzymes that break down fat, which is absorbed by the body. Orlistat decreases the absorption of fat from the food you eat. Thus, fat passes through the gut and is excreted in the faeces, which makes the body unable to use fat as a source of energy or convert it into fat tissue. Thereby, Orlistat helps in weight loss.
Take Orlistat as prescribed by your doctor. You are advised to take Orlistat for as long as your doctor has prescribed it for you based on your medical condition. Some people may experience soft stools, sudden bowel motions, flatulence (gas) with or without oily spotting, oily or fatty stools, stomach pain, stool incontinence (involuntary leakage of stools), and runny or liquid stools. Most of these side effects of Orlistat do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Orlistat or any other medicines, please tell your doctor. Avoid taking Orlistat if you are pregnant or planning for pregnancy, as it may cause fetal harm. It is not known whether Orlistat is excreted in human milk. Therefore, please consult a doctor if you are a breastfeeding woman. Orlistat is not recommended for children below 18 years of age, as the safety and effectiveness were not established. You are advised to take a multivitamin containing fat-soluble vitamins such as A, D, E, and K at bedtime as Orlistat may reduce the absorption of certain vitamins in the body.
ContraindicationsOrlistat is not recommended for people who have following health conditions:
Tell your doctor if you experience any of these symptoms:
Stade de France Pharmacy